Eli Lilly (LLY 1.15%) and Novo Nordisk (NVO 0.14%) are two phenomenal growth stocks that investors probably can't go wrong ...

Medtronic's decision to spin off its higher-growth diabetes segment seems odd -- until we realize that, although it had a positive effect on the top line, it was dragging down margins and the bottom ...

Sensata's long-term growth potential in EVs, automation, and aerospace. With a discounted valuation, explore why ST stock ...

Americans are badly misinformed about the basics of long-term care, a point driven home in numerous surveys and studies. One ...